GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

1,566.00p
   
  • Change Today:
      41.40p
  • 52 Week High: 1,621.60
  • 52 Week Low: 1,273.80
  • Currency: UK Pounds
  • Shares Issued: 4,966.39m
  • Volume: 8,296,551
  • Market Cap: 77,774m
  • RiskGrade: 86
  • Beta: 0.01

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 5.1% 5.3%
Div Cover 1.5 1.4
Op Mrgn 17.8% 24.0%
ROCE 64.2%  
Latest F'cast
P/E 13.1 13.9
PEG 1.9 n/a
Pr/Revenue 2.5 2.4
Pr/Book 21.2  
Latest F'cast
Revenue 2.1% 3.3%
PBT 36.2% 59.0%
EPS 6.8% -7.8%
DPS n/a -0.0%

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%
31-Dec-18 30,821.00 4,800.00 119.40p 12.5 1.8 +7% 80.00p 5.4%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 31,826.80 7,630.89 110.12p 14.2 n/a -8% 79.97p 5.3%
31-Dec-20 34,185.39 8,253.22 115.37p 13.6 2.9 +5% 79.97p 5.3%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
11-Mar-19 Transfer From Victoria Whyte 0.000p 8 0.00
11-Mar-19 Buy Victoria Whyte 1,527.59p 8 122.21
11-Mar-19 Transfer From David Redfern 0.000p 8 0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,566.00p
Change Today 41.40p
% Change 2.72 %
52 Week High 1,621.60
52 Week Low 1,273.80
Volume 8,296,551
Shares Issued 4,966.39m
Market Cap 77,774m
Beta 0.01
RiskGrade 86

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55.84% below the market average55.84% below the market average55.84% below the market average55.84% below the market average55.84% below the market average
13.79% above the sector average13.79% above the sector average13.79% above the sector average13.79% above the sector average13.79% above the sector average
Price Trend
52.58% above the market average52.58% above the market average52.58% above the market average52.58% above the market average52.58% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Income
64.33% above the market average64.33% above the market average64.33% above the market average64.33% above the market average64.33% above the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average
Growth
6.18% above the market average6.18% above the market average6.18% above the market average6.18% above the market average6.18% above the market average
26.32% below the sector average26.32% below the sector average26.32% below the sector average26.32% below the sector average26.32% below the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 14
Sell 0
Strong Sell 2
Total 19
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q4 Q3
Ex-Div 21-Feb-19 15-Nov-18
Paid 11-Apr-19 10-Jan-19
Amount 23.00p 19.00p

Trades for 21-Mar-2019

Time Volume / Share Price
17:14 16,205 @ 1,548.78p
17:14 34 @ 1,548.79p
17:13 33,761 @ 1,548.78p
16:39 774 @ 1,566.00p
16:39 1,726 @ 1,566.00p

GlaxoSmithKline Key Personnel

CFO Simon Dingemans
CEO Emma Walmsley

Top of Page